Safety Study of AADC Gene Therapy (VY-AADC01) for Parkinson's Disease
Clinical trial NCT01973543 · COMPLETED
Trial details
- NCT number
- NCT01973543
- Sponsor
- Neurocrine Biosciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2020-01-24
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.